TITLE

Proposed Part D rule changes could be bane to brand drugmakers

AUTHOR(S)
Serebrov, Mari
PUB. DATE
January 2014
SOURCE
BioWorld Today;1/8/2014, Vol. 25 Issue 5, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the U.S. Centers for Medicare & Medicaid Services' proposal of Part D rule change that would tip the formulary scale in favor of generics and biosimilars which is seen as a bane to pharmaceutical firms. The changes aims to remove the protection antidepressants and immunosuppresants have enjoyed under Part D. They would also offer coverage exceptions to encourage lower drug prices and control off-label use.
ACCESSION #
93618403

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics